Periplocymarin |
Katalog-Nr.GC39059 |
Periplocymarin, ein aus Periploca sepium und Periploca graeca isoliertes Herzglykosid, ist eine potenzielle Antikrebsverbindung.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 32476-67-8
Sample solution is provided at 25 µL, 10mM.
Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer compound[1][2].
[1]. Martey ON, et al. Periplocymarin is a potential natural compound for drug development: highly permeable with absence of P-glycoprotein efflux and cytochrome P450 inhibitions. Biopharm Drug Dispos. 2014 May;35(4):195-206. [2]. Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfidebond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy. Drug Deliv. 2017 Nov;24(1):1170-1178.
Average Rating: 5
(Based on Reviews and 33 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *